Casslén B, Sandberg T, Gustavsson B, Willén R, Nilbert M
Department of Obstetrics & Gynecology, University Hospital, Lund, Sweden.
Biol Reprod. 1998 Jun;58(6):1343-50. doi: 10.1095/biolreprod58.6.1343.
The purpose of this study was to identify cyclic variations and hormonal regulation of endometrial transforming growth factor beta1 (TGFbeta1) mRNA. Regulation of the plasminogen-activating system was also examined, since it is involved in activation of latent TGFbetas. We measured TGFbeta1 mRNA in 51 normal endometrial samples by Northern blot and densitometric scanning of autoradiograms. Each value was related to the corresponding beta-actin value to allow quantitative evaluation. TGFbeta1 mRNA was higher in the mid and late secretory and menstrual phases than in the earlier parts of the cycle. This pattern implies progesterone dependence. The content of TGFbeta1 mRNA in endometrial tissue explants obtained in the proliferative phase was significantly increased after stimulation for 4 days with estradiol + progesterone in vitro. Both TGFbeta1 and estradiol + progesterone increased the content of plasminogen activator inhibitor-1 mRNA and protein in primary cultures of endometrial stromal cells. Conditioned-medium concentrations of urokinase plasminogen activator (u-PA) were increased by TGFbeta1, but decreased by estradiol + progesterone. This effect of estradiol + progesterone results from increased internalization and degradation of u-PA secondary to up-regulation of the cell surface receptor for u-PA by progesterone (Casslén et al., JCEM 1995; 80: 2776-2784). Increased extracellular u-PA in response to TGFbeta1 exposure was thus in concordance with an unchanged amount of available u-PA receptors on the cell surface. The activation mechanism of latent TGFbeta involves u-PA activity; since u-PA activity is reduced in the secretory endometrium, we suggest that although TGFbeta1 mRNA is increased in the mid and late secretory phase, TGFbetas are mainly in their latent form until the premenstrual rise in u-PA activity stimulates activation. TGFbeta may promote capillary growth during endometrial regeneration.
本研究的目的是确定子宫内膜转化生长因子β1(TGFβ1)mRNA的周期性变化及其激素调节。同时也研究了纤溶酶原激活系统的调节,因为它参与了潜在TGFβ的激活。我们通过Northern印迹法和放射自显影片的光密度扫描,测量了51份正常子宫内膜样本中的TGFβ1 mRNA。每个值都与相应的β-肌动蛋白值相关,以便进行定量评估。TGFβ1 mRNA在分泌期中期和后期以及月经期高于月经周期的早期阶段。这种模式表明其依赖于孕酮。增殖期获取的子宫内膜组织外植体,在体外经雌二醇+孕酮刺激4天后,TGFβ1 mRNA的含量显著增加。TGFβ1以及雌二醇+孕酮均可增加子宫内膜基质细胞原代培养物中纤溶酶原激活物抑制剂-1 mRNA和蛋白的含量。TGFβ1可使尿激酶型纤溶酶原激活物(u-PA)的条件培养基浓度升高,但雌二醇+孕酮则使其降低。雌二醇+孕酮的这种作用是由于孕酮上调u-PA细胞表面受体后,导致u-PA内化和降解增加所致(Casslén等人,《临床内分泌与代谢杂志》1995年;80:2776 - 2784)。因此,TGFβ1暴露后细胞外u-PA增加,这与细胞表面可用u-PA受体数量未变一致。潜在TGFβ的激活机制涉及u-PA活性;由于分泌期子宫内膜中u-PA活性降低,我们认为尽管TGFβ1 mRNA在分泌期中期和后期增加,但TGFβ主要以潜伏形式存在,直到经前u-PA活性升高刺激激活。TGFβ可能在子宫内膜再生过程中促进毛细血管生长。